Intrinsic Capital Partners

Nalu Bio Secures 12M In Series A Funding Round Led By Intrinsic Capital Partners

Nalu Bio has raised a $12 million series A funding round. The round was led by Intrinsic Capital Partners, with participation from Flybridge Capital Partners, Portfolia Active Aging & Longevity Fund, Bonaventure Equity, L37 Ventures, Golden Seeds, Sacramento Angels, Brown Angel Group, and Axial Venture.

Cannabis Lab Testing Company ACT To Acquire CDX Analytics

ACT Laboratories, Inc., a lab testing company in the legal cannabis and hemp markets, entered into an agreement to acquire CDX Analytics, LLC of Massachusetts.